Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Zhou

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Global Epidemiology|August 28, 2023
Systematic review of perchloroethylene and non-Hodgkin's lymphomaJulie E Goodman, Rebecca C Ticknor, Jean Zhou
Global Epidemiology|August 28, 2023
Response: Alternative approaches for systematic reviewJulie E Goodman, Rebecca C Ticknor, Jean Zhou
The Journal of Organic Chemistry|July 17, 2004
10-hydroxy-10,9-boroxarophenanthrenes: versatile synthetic intermediates to 3,4-benzocoumarins and triarylsQ Jean Zhou, Karin Worm, Roland E Dolle
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Biaryl cannabinoid mimetics--synthesis and structure-activity relationshipKarin Worm, Q Jean Zhou, Gabriel J Stabley, et al.
Environmental Pollution (Barking, Essex : 1987)|January 26, 2024
Nickel in ambient particulate matter and respiratory or cardiovascular outcomes: A critical reviewWenchao Li, Jean Zhou, Denali Boon, et al.
Regulatory Toxicology and Pharmacology : RTP|June 1, 2023
Systematic review of the potential carcinogenicity of bisphenol A in humansRobyn L Prueitt, Mary L Hixon, Tongyao Fan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 16, 2016
Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastomaNoelyn A Hung, Ramona A Eiholzer, Stenar Kirs, et al.
The Journal of Pathology|June 12, 2018
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor developmentMarina Kazantseva, Ramona A Eiholzer, Sunali Mehta, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Global Epidemiology|August 28, 2023
Systematic review of perchloroethylene and non-Hodgkin's lymphomaJulie E Goodman, Rebecca C Ticknor, Jean Zhou
Global Epidemiology|August 28, 2023
Response: Alternative approaches for systematic reviewJulie E Goodman, Rebecca C Ticknor, Jean Zhou
The Journal of Organic Chemistry|July 17, 2004
10-hydroxy-10,9-boroxarophenanthrenes: versatile synthetic intermediates to 3,4-benzocoumarins and triarylsQ Jean Zhou, Karin Worm, Roland E Dolle
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Biaryl cannabinoid mimetics--synthesis and structure-activity relationshipKarin Worm, Q Jean Zhou, Gabriel J Stabley, et al.
Environmental Pollution (Barking, Essex : 1987)|January 26, 2024
Nickel in ambient particulate matter and respiratory or cardiovascular outcomes: A critical reviewWenchao Li, Jean Zhou, Denali Boon, et al.
Regulatory Toxicology and Pharmacology : RTP|June 1, 2023
Systematic review of the potential carcinogenicity of bisphenol A in humansRobyn L Prueitt, Mary L Hixon, Tongyao Fan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 16, 2016
Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastomaNoelyn A Hung, Ramona A Eiholzer, Stenar Kirs, et al.
The Journal of Pathology|June 12, 2018
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor developmentMarina Kazantseva, Ramona A Eiholzer, Sunali Mehta, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Pageof 1